Literature DB >> 2997238

Human spreading factor: synthesis and response by HepG2 hepatoma cells in culture.

D W Barnes, J Reing.   

Abstract

Human serum spreading factor (SF) is a cell adhesion and spreading-promoting glycoprotein purified from serum or plasma that mediates effects in a wide variety of animal cell culture systems. HepG2 human hepatoma cells were found to synthesize and secrete SF into culture medium. Quantitative immunoassay of the protein indicated a concentration of about 1 microgram/ml in 48 hr-conditioned medium from confluent cultures. Although fibronectin also was synthesized and secreted into the culture medium, HepG2 cell spreading was observed in response to human serum SF, but not in response to human plasma fibronectin. Immunoprecipitation of SF from culture medium of cells metabolically-labeled with leucine, fucose or glucosamine identified a single form of the molecule of approximately 70,000 daltons. Treatment of cultures with tunicamycin inhibited incorporation of fucose and glucosamine into immunoprecipitated SF, but did not prevent synthesis and secretion of the protein. Electrophoretic analysis and cell spreading assays showed that SF secreted by tunicamycin-treated HepG2 cells was of molecular weight (mw) approximately 60,000, and was biologically active.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2997238     DOI: 10.1002/jcp.1041250206

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  8 in total

Review 1.  Evidence for an extra-cellular function for protein kinase A.

Authors:  S Shaltiel; I Schvartz; B Korc-Grodzicki; T Kreizman
Journal:  Mol Cell Biochem       Date:  1993-11       Impact factor: 3.396

2.  Human and mouse S-protein mRNA detected in northern blot experiments and evidence for the gene encoding S-protein in mammals by Southern blot analysis.

Authors:  M Solem; A Helmrich; P Collodi; D Barnes
Journal:  Mol Cell Biochem       Date:  1991-02-02       Impact factor: 3.396

3.  Detection of vitronectin mRNA in tissues and cells of the mouse.

Authors:  D Seiffert; M Keeton; Y Eguchi; M Sawdey; D J Loskutoff
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

4.  Vitronectin secretion by hepatic and non-hepatic human cancer cells.

Authors:  H Yasumitsu; N Seo; E Misugi; H Morita; K Miyazaki; M Umeda
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-05       Impact factor: 2.416

5.  Evidence that extrahepatic cells express vitronectin mRNA at rates approaching those of hepatocytes.

Authors:  D Seiffert; G M Bordin; D J Loskutoff
Journal:  Histochem Cell Biol       Date:  1996-03       Impact factor: 4.304

6.  Serum-derived vitronectin influences the pericellular distribution of type 1 plasminogen activator inhibitor.

Authors:  D Seiffert; N N Wagner; D J Loskutoff
Journal:  J Cell Biol       Date:  1990-09       Impact factor: 10.539

7.  Vitronectins produced by human cirrhotic liver and CCl4-treated rats differ in their glycosylation pattern and tissue remodeling activity.

Authors:  Kimie Date; Risa Suzuki; Sachie Oda-Tamai; Haruko Ogawa
Journal:  FEBS Open Bio       Date:  2019-03-18       Impact factor: 2.693

8.  Screening of hepatocyte proteins binding with C‑terminally truncated surface antigen middle protein of hepatitis B virus (MHBst167) by a yeast two‑hybrid system.

Authors:  Zhi Qun Li; Enqiang Linghu; Wan Jun; Jun Cheng
Journal:  Mol Med Rep       Date:  2014-06-26       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.